CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.
Símbolo de cotizaciónCBLL
Nombre de la empresaCeriBell Inc
Fecha de salida a bolsaOct 11, 2024
Fundada en2014
Director ejecutivoMs. Xingjuan (Jane) Chao, Ph.D.
Número de empleados281
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 11
Dirección360 N. Pastoria Avenue
CiudadSUNNYVALE
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal94085
Teléfono18004360826
Sitio Webhttps://ceribell.com/
Símbolo de cotizaciónCBLL
Fecha de salida a bolsaOct 11, 2024
Fundada en2014
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos